LifeStance, Private Equity Rollup Turned Organic Growth Stock, Targets A Profound Void
Detailed summary
LifeStance stock has doubled this year and analysts foresee big time earnings growth. But "the bar is higher" now. The post LifeStance, Private Equity Rollup Turned Organic Growth…
LifeStance Health (LFST) stock has been on a tear this year, doubling in value and outpacing several of its telehealth peers, including Teladoc Health (TDOC), Hims & Hers Health (HIMS) and Doximity (DOCS). The behavioral health services company, built rollup-style through about 100 acquisitions and private-equity backing, is now delivering double-digit revenue growth and clinician adds, with some organic growth…
Opening of the article, excerpted from Investor's Business Daily. To read the rest, open the article on the publisher's site.
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.investors.com)